CN111743144A - Double-mushroom composite peptide composition and preparation method and application thereof - Google Patents
Double-mushroom composite peptide composition and preparation method and application thereof Download PDFInfo
- Publication number
- CN111743144A CN111743144A CN202010560835.8A CN202010560835A CN111743144A CN 111743144 A CN111743144 A CN 111743144A CN 202010560835 A CN202010560835 A CN 202010560835A CN 111743144 A CN111743144 A CN 111743144A
- Authority
- CN
- China
- Prior art keywords
- powder
- parts
- double
- mushroom
- stabilizer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title claims abstract description 87
- 239000000203 mixture Substances 0.000 title claims abstract description 58
- 239000002131 composite material Substances 0.000 title claims abstract description 44
- 238000002360 preparation method Methods 0.000 title claims abstract description 30
- 239000000843 powder Substances 0.000 claims abstract description 106
- 239000003381 stabilizer Substances 0.000 claims abstract description 67
- 235000013361 beverage Nutrition 0.000 claims abstract description 53
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims abstract description 46
- 244000251953 Agaricus brunnescens Species 0.000 claims abstract description 36
- 150000001875 compounds Chemical class 0.000 claims abstract description 35
- 239000002994 raw material Substances 0.000 claims abstract description 34
- 241000196324 Embryophyta Species 0.000 claims abstract description 29
- 240000006499 Flammulina velutipes Species 0.000 claims abstract description 27
- 235000016640 Flammulina velutipes Nutrition 0.000 claims abstract description 27
- 235000018102 proteins Nutrition 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 21
- 239000006041 probiotic Substances 0.000 claims abstract description 17
- 235000018291 probiotics Nutrition 0.000 claims abstract description 17
- 241000209140 Triticum Species 0.000 claims abstract description 15
- 235000021307 Triticum Nutrition 0.000 claims abstract description 15
- 230000000529 probiotic effect Effects 0.000 claims abstract description 15
- 108010073771 Soybean Proteins Proteins 0.000 claims abstract description 10
- 235000019710 soybean protein Nutrition 0.000 claims abstract description 10
- 229940054810 white kidney bean extract Drugs 0.000 claims abstract description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 57
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 240000000851 Vaccinium corymbosum Species 0.000 claims description 33
- 235000003095 Vaccinium corymbosum Nutrition 0.000 claims description 33
- 235000017537 Vaccinium myrtillus Nutrition 0.000 claims description 33
- 235000021014 blueberries Nutrition 0.000 claims description 33
- 240000001717 Vaccinium macrocarpon Species 0.000 claims description 26
- 235000012545 Vaccinium macrocarpon Nutrition 0.000 claims description 23
- 235000002118 Vaccinium oxycoccus Nutrition 0.000 claims description 23
- 235000004634 cranberry Nutrition 0.000 claims description 23
- 229920001202 Inulin Polymers 0.000 claims description 20
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims description 20
- 229940029339 inulin Drugs 0.000 claims description 20
- UQZIYBXSHAGNOE-USOSMYMVSA-N Stachyose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](CO[C@@H]2[C@@H](O)[C@@H](O)[C@@H](O)[C@H](CO)O2)O1 UQZIYBXSHAGNOE-USOSMYMVSA-N 0.000 claims description 19
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 claims description 19
- 229940107187 fructooligosaccharide Drugs 0.000 claims description 19
- UQZIYBXSHAGNOE-XNSRJBNMSA-N stachyose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO[C@@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)O2)O)O1 UQZIYBXSHAGNOE-XNSRJBNMSA-N 0.000 claims description 19
- 244000269722 Thea sinensis Species 0.000 claims description 18
- 235000009569 green tea Nutrition 0.000 claims description 18
- 229920001285 xanthan gum Polymers 0.000 claims description 18
- 239000000230 xanthan gum Substances 0.000 claims description 18
- 235000010493 xanthan gum Nutrition 0.000 claims description 18
- 229940082509 xanthan gum Drugs 0.000 claims description 18
- 229920000161 Locust bean gum Polymers 0.000 claims description 16
- 239000000711 locust bean gum Substances 0.000 claims description 16
- 235000010420 locust bean gum Nutrition 0.000 claims description 16
- 229920002752 Konjac Polymers 0.000 claims description 15
- 235000010485 konjac Nutrition 0.000 claims description 15
- 244000247812 Amorphophallus rivieri Species 0.000 claims description 14
- 235000001206 Amorphophallus rivieri Nutrition 0.000 claims description 14
- 238000001914 filtration Methods 0.000 claims description 14
- 239000000252 konjac Substances 0.000 claims description 14
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 claims description 14
- 229940048086 sodium pyrophosphate Drugs 0.000 claims description 14
- 235000019818 tetrasodium diphosphate Nutrition 0.000 claims description 14
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 13
- 230000001954 sterilising effect Effects 0.000 claims description 12
- 239000004744 fabric Substances 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 238000009835 boiling Methods 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 239000000706 filtrate Substances 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 5
- 239000000084 colloidal system Substances 0.000 claims description 4
- 241001134770 Bifidobacterium animalis Species 0.000 claims description 3
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 3
- 238000007605 air drying Methods 0.000 claims description 3
- 235000015197 apple juice Nutrition 0.000 claims description 3
- 229940118852 bifidobacterium animalis Drugs 0.000 claims description 3
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 3
- 238000004140 cleaning Methods 0.000 claims description 3
- 235000021019 cranberries Nutrition 0.000 claims description 3
- 238000011049 filling Methods 0.000 claims description 3
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000010438 heat treatment Methods 0.000 claims description 3
- 238000004537 pulping Methods 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 235000013312 flour Nutrition 0.000 claims 1
- 235000013311 vegetables Nutrition 0.000 claims 1
- 239000000796 flavoring agent Substances 0.000 abstract description 12
- 235000019634 flavors Nutrition 0.000 abstract description 11
- 235000013305 food Nutrition 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 238000012545 processing Methods 0.000 abstract description 2
- 230000000087 stabilizing effect Effects 0.000 abstract description 2
- 238000003860 storage Methods 0.000 abstract description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- 230000000052 comparative effect Effects 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 230000036772 blood pressure Effects 0.000 description 7
- 238000011156 evaluation Methods 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- 239000004472 Lysine Substances 0.000 description 5
- 102000015636 Oligopeptides Human genes 0.000 description 5
- 108010038807 Oligopeptides Proteins 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 239000004475 Arginine Substances 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 230000001093 anti-cancer Effects 0.000 description 4
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 4
- 235000012000 cholesterol Nutrition 0.000 description 4
- 230000029087 digestion Effects 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000011707 mineral Substances 0.000 description 4
- 235000010755 mineral Nutrition 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 229920001282 polysaccharide Polymers 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 3
- 240000007440 Agaricus campestris Species 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 3
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 3
- 108010064851 Plant Proteins Proteins 0.000 description 3
- -1 VB1 Natural products 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 235000021118 plant-derived protein Nutrition 0.000 description 3
- 235000004570 Agaricus campestris Nutrition 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010047623 Vitamin C deficiency Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000021552 granulated sugar Nutrition 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 208000010233 scurvy Diseases 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 238000002137 ultrasound extraction Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- 102000005862 Angiotensin II Human genes 0.000 description 1
- 101800000733 Angiotensin-2 Proteins 0.000 description 1
- 102000004881 Angiotensinogen Human genes 0.000 description 1
- 108090001067 Angiotensinogen Proteins 0.000 description 1
- 102000015427 Angiotensins Human genes 0.000 description 1
- 108010064733 Angiotensins Proteins 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000007516 Chrysanthemum Nutrition 0.000 description 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 1
- 244000183685 Citrus aurantium Species 0.000 description 1
- 235000007716 Citrus aurantium Nutrition 0.000 description 1
- 235000005976 Citrus sinensis Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 108010010234 HDL Lipoproteins Proteins 0.000 description 1
- 102000015779 HDL Lipoproteins Human genes 0.000 description 1
- YZJSUQQZGCHHNQ-UHFFFAOYSA-N Homoglutamine Chemical compound OC(=O)C(N)CCCC(N)=O YZJSUQQZGCHHNQ-UHFFFAOYSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- CZGUSIXMZVURDU-JZXHSEFVSA-N Ile(5)-angiotensin II Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CC=1C=CC=CC=1)C([O-])=O)NC(=O)[C@@H](NC(=O)[C@H](CCCNC(N)=[NH2+])NC(=O)[C@@H]([NH3+])CC([O-])=O)C(C)C)C1=CC=C(O)C=C1 CZGUSIXMZVURDU-JZXHSEFVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 108010028554 LDL Cholesterol Proteins 0.000 description 1
- 108010007622 LDL Lipoproteins Proteins 0.000 description 1
- 102000007330 LDL Lipoproteins Human genes 0.000 description 1
- 229920000057 Mannan Polymers 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 244000252132 Pleurotus eryngii Species 0.000 description 1
- 235000001681 Pleurotus eryngii Nutrition 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229950006323 angiotensin ii Drugs 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 235000008452 baby food Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- BJHIKXHVCXFQLS-UYFOZJQFSA-N fructose group Chemical group OCC(=O)[C@@H](O)[C@H](O)[C@H](O)CO BJHIKXHVCXFQLS-UYFOZJQFSA-N 0.000 description 1
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000007413 intestinal health Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 108010022197 lipoprotein cholesterol Proteins 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000004698 lymphocyte Anatomy 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000015816 nutrient absorption Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000013112 stability test Methods 0.000 description 1
- 238000012430 stability testing Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Botany (AREA)
- Non-Alcoholic Beverages (AREA)
Abstract
The invention belongs to the technical field of food processing, and particularly relates to a double-mushroom composite peptide composition and a preparation method and application thereof. The double-mushroom compound peptide plant composition provided by the invention comprises the following raw materials in parts by weight: the composition is characterized by comprising the following raw materials in parts by weight: 30-70 parts of probiotic agaricus bisporus and flammulina velutipes composite powder, 1-20 parts of fermented wheat protein peptide powder, 1-10 parts of fermented soybean protein peptide powder and 1-40 parts of white kidney bean extract. The invention also provides an application of the double-mushroom compound peptide composition and a preparation method thereof. The invention can greatly reduce the use of the stabilizer, can achieve better stabilizing effect and keep good flavor and taste of the beverage, also saves the manufacturing cost, and can also improve the storage stability and the uniformity and the stability of the product quality.
Description
Technical Field
The invention belongs to the technical field of food processing, and particularly relates to a double-mushroom composite peptide composition and a preparation method and application thereof.
Background
The agaricus bisporus, also called white mushroom, is fleshy, contains more mannose, trehalose and various amino acids, is delicious in taste and rich in nutrition, is rich in protein, fat, carbohydrate and various trace elements, and also contains a large amount of vitamins. Agaricus bisporus contains 8 essential amino acids for human body, among which tryptophan and lysine are deficient in general plant proteins. The Agaricus campestris polysaccharide and protein contained in Agaricus bisporus have anticancer activity, and have effects of preventing cancer, refreshing, promoting digestion, lowering blood pressure, and preventing and treating scurvy. The needle mushroom is rich in protein, also contains various vitamins such as VB1, VB2, VC and the like, is rich in various mineral substances such as calcium, phosphorus, iron and the like, and is very rich in nutrition. The needle mushroom also contains 18 kinds of amino acids, the content of arginine and lysine in the essential amino acids is higher, and the content of lysine and arginine in per 100g of dry product is respectively 1.024g and 1.231g, which is higher than that of common mushrooms. The product is rich in arginine, lysine, various minerals and vitamins, and has important effect in improving intelligence of children. The needle mushroom also contains functional components with unique effects, such as proteins with various pharmacological effects, polysaccharides with anticancer effects, and the like. Agaricus bisporus and Flammulina velutipes can be directly eaten, and can be processed into flavoring agent, beverage, etc.
Chinese patent application CN105475766A discloses a compound mushroom beverage, which is composed of agaricus bisporus, pleurotus eryngii, peanut skin, blueberry, chrysanthemum, seville orange flower, isomaltooligosaccharide, citric acid, malic acid, xylitol and water. The invention also discloses a preparation method of the composite mushroom beverage. The composite mushroom beverage disclosed by the invention is cool in taste, sour and sweet in taste, integrates health care and nutrition, has the effects of invigorating stomach, helping digestion, moistening lung, regulating qi, promoting blood circulation and reducing blood fat, and can also enhance the immunity and physique of a human body.
The corn oligopeptide powder is produced by using corn protein powder as a raw material and carrying out processes of size mixing, protease enzymolysis, separation, filtration, spray drying and the like, has the excellent characteristics of peptide substances, namely the characteristics of direct absorption, strong solubility, strong stability, high safety and the like superior to amino acid or protein, and can be applied to blood pressure reduction, sobering and liver protection and immunity enhancement.
The soybean peptide powder is a mixed peptide product which consists of 2-6 amino acids and has the molecular weight of 200-. Compared with the original protein, the soybean peptide powder has good water solubility, water retention and foamability, is easy to be absorbed by human bodies, has various physiological activities including antioxidation, blood pressure reduction, cholesterol reduction, blood fat reduction, fatigue resistance, immunity enhancement and the like, and can be widely used for health-care food, infant food, sports food, fermented products, clinical nutritional preparations and the like.
In the production process of the beverage containing protein and polypeptide, a stabilizer is often required to be added to stabilize and thicken the beverage, prevent precipitation and stratification and play an important role in the stability and the tissue structure of the beverage, but if the stabilizer is added too much, the flavor and the taste are obviously influenced.
Chinese patent application CN105983078A discloses a plant protein beverage for strengthening brain and improving intelligence and a preparation method thereof, wherein the beverage is prepared by soaking pulp of the plant protein beverage in 2-10 times of 0.1-1% sodium bicarbonate water solution for 8-16 hours. Grinding into homogenate with a grinder, boiling, filtering, adding 25% stabilizer and 25% granulated sugar water solution to obtain emulsion, homogenizing twice with a high pressure homogenizer, sterilizing, bottling, and sterilizing again. The beverage stabilizer is 1.2% of sucrose fatty acid ester and monoglyceride (ratio is 1: 0.5-2) water solution, and 25% of granulated sugar water solution.
The stabilizer is used in the beverage very commonly, but different stabilizers are needed for different types and components of beverages, and on the other hand, the consumption of the stabilizer in the common beverage is large, which not only causes the problem of cost, but also has certain influence on the flavor and taste of the beverage. Therefore, the use amount of the stabilizer is reduced, the flavor, taste and quality of the beverage are not influenced, and the beverage has practical significance and value.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention aims to provide a double-mushroom compound peptide composition, a preparation method and application thereof, so as to solve the defects.
The invention provides a double-mushroom composite peptide composition which is prepared from the following raw materials in parts by weight: 30-70 parts of probiotic agaricus bisporus and flammulina velutipes composite powder, 1-20 parts of fermented wheat protein peptide powder, 1-10 parts of fermented soybean protein peptide powder and 1-4 parts of white kidney bean extract.
The preparation method of the probiotic agaricus bisporus and flammulina velutipes composite powder comprises the following steps:
(1) cleaning Agaricus bisporus and Flammulina velutipes (Fr.) Sing respectively, decocting in boiling water for 2 min, air drying, adding 8 times of water, crushing, centrifuging, collecting supernatant, filtering with filter cloth for 3 times, collecting filtrate, and freeze drying to obtain Agaricus bisporus dry powder and Flammulina velutipes dry powder;
(2) weighing 20-30 parts of agaricus bisporus dry powder and 15-25 parts of flammulina velutipes dry powder in parts by weight, mixing, sterilizing, homogenizing at the homogenizing pressure of 10-13 MPa for 0.5-2.5 hours, and cooling the homogenized mixture to room temperature to obtain homogenized powder;
(3) and adding lactobacillus rhamnosus, bifidobacterium animalis and bifidobacterium lactis, and mixing at the temperature of 25-36 ℃ for 0.5-3 hours to obtain the lactobacillus acidophilus milk.
The invention also provides a preparation method of the double-mushroom composite peptide composition, which comprises the following steps:
weighing probiotic agaricus bisporus and flammulina velutipes composite powder, fermented wheat protein peptide powder, fermented soybean protein peptide powder and white kidney bean extract according to the weight ratio, mixing and uniformly stirring to obtain the agaricus bisporus composite peptide composition.
The invention also provides an application of the double-mushroom compound peptide composition in plant beverage, wherein the plant beverage comprises the following raw materials in percentage by weight:
3-8% of double-mushroom compound peptide composition, 10-18% of fructo-oligosaccharide, 1-4% of cranberry concentrated juice, 1-4% of blueberry concentrated juice, 1-5% of stachyose, 0.05-0.3% of green tea powder, 0.05-0.3% of green coffee powder, 0.1-0.3% of citric acid, 0.1-1% of stabilizer and the balance of water.
Further, the plant beverage is prepared from the following raw materials in percentage by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5% of stabilizing agent and the balance of water.
Further, the stabilizer comprises the following raw material components: konjac fine powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin.
Furthermore, the stabilizing agent comprises the raw materials of konjac refined powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin according to the weight ratio of 1 (1-1.5) to 1-2 (0.5-1) to 3-6.
Furthermore, the raw materials of the stabilizer are konjac refined powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin, and the weight ratio of the konjac refined powder to the inulin is 1:1.2:1.5:0.7: 5.
The preparation method of the plant beverage comprises the following steps:
s1, preparing cranberry juice and blueberry juice: respectively taking fresh cranberries and blueberries, adding 3-5 times of water by weight, pulping, roughly filtering with 50-mesh filter cloth, filtering with 200-mesh filter cloth, taking filtered juice, and vacuum concentrating to obtain cranberry concentrated juice and blueberry concentrated juice;
s2, weighing the stabilizer, grinding the stabilizer by using a colloid mill, mixing the stabilizer with the double-mushroom composite peptide composition, adding water to dissolve the stabilizer, stirring the mixture uniformly, heating and boiling the mixture for 5 to 10 minutes, cooling the mixture, and homogenizing the mixture by using a high-pressure homogenizer; and adding fructo-oligosaccharide, stachyose, green tea powder, green coffee powder, citric acid, the apple juice and the blueberry juice prepared in the step S1, homogenizing twice, filtering, sterilizing and filling to obtain the blueberry juice.
Preferably, the extraction conditions in step S1 are such that the aqueous solution is heated to 40-50 deg.C and the ultrasonic extraction time is 20-40 minutes.
Preferably, the combined filtrate in step S1 is concentrated to a density of 1.0-1.2g/cm3。
Preferably, in step S4, the stabilizer is colloid-milled for 15-35 minutes, and the particle size of the milled stabilizer is 10-15 μm. The sterilization temperature in step S4 is 110 ℃, and the sterilization time is 5-15 minutes.
The invention provides a agaricus bisporus and flammulina velutipes compound peptide plant beverage which mainly comprises probiotics agaricus bisporus and flammulina velutipes compound powder, fermented wheat protein peptide powder, fermented soybean protein peptide powder, white kidney bean extract, fructo-oligosaccharide, cranberry concentrated juice, blueberry concentrated juice, stachyose and the like. The probiotic agaricus bisporus and flammulina velutipes composite powder has various beneficial effects on a human body, and the probiotic has the effects of regulating the host mucous membrane and system immunity function or promoting nutrient absorption to keep intestinal tract health by regulating the balance of flora in the intestinal tract; agaricus campestris polysaccharide and protein contained in Agaricus bisporus have certain anticancer activity, and have effects of preventing cancer, refreshing mind, promoting digestion, lowering blood pressure, and preventing and treating scurvy. The needle mushroom is rich in arginine, lysine, various mineral substances and vitamins, and has important effect on improving intelligence of children. The needle mushroom also contains functional components with unique effects, such as proteins with various pharmacological effects, polysaccharides with anticancer effects, and the like. The efficacy of the probiotic bacteria can be further enhanced by the compound use of the probiotic bacteria, the agaricus bisporus and the flammulina velutipes.
The wheat oligopeptide contained in the wheat protein peptide powder has the functions of inhibiting the rise of cholesterol and promoting the secretion of insulin, and the functional substance of the wheat oligopeptide is the oligomethionine, so that the wheat oligopeptide can be used for regulating the blood sugar of a human body and improving the symptoms of diabetes. Can block the action of angiotensin enzyme, and thus has effect in lowering blood pressure. The wheat oligopeptide contains homoglutamine, can effectively regulate nerves, can be used as a special nutrient substance for intestinal dysfunction, has multiple biological activities such as ACE (angiotensin converting enzyme) inhibition, immunoregulation, oxidation resistance and the like, can stimulate lymphocyte proliferation of an organism, enhances the phagocytosis function of macrophages, improves the capability of the organism for resisting infection of external pathogens, reduces the morbidity of the organism and the like. Can inhibit the activity of angiotensin converting enzyme, and inhibit the conversion of angiotensinogen into angiotensin II which can increase blood pressure, thereby lowering blood pressure physiologically. The addition of the cranberry juice and the blueberry juice increases cellulose and vitamins, enriches the taste of the beverage and is more easily accepted by people.
The stabilizing agent adopted by the double-mushroom composite peptide plant beverage is konjak fine powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin. The rhizoma Amorphophalli refined powder contains mannan and glucose as main ingredients, and can be used as gelatinizer, thickener, emulsifier, stabilizer, and film-forming agent, and also can effectively reduce cholesterol and blood sugar and reduce weight, and can be used for treating hyperlipidemia, diabetes, obesity, constipation, etc. The xanthan gum has unique rheological property, good water solubility, stability to heat and acid and alkali and good compatibility with various salts, and is an excellent thickening agent, suspending agent, emulsifying agent and stabilizing agent. Inulin, also known as inulin, is a mixture of natural fructans, which is a carbohydrate with fructose units linked by (2-1) chains and terminated by glucose units, and is effective in lowering serum total cholesterol and low density lipoprotein cholesterol, increasing the high density lipoprotein/low density lipoprotein ratio, improving blood lipid conditions, and in addition, inulin does not cause elevated glucose carbohydrates in urine, and it is not hydrolyzed to monosaccharides in the upper part of the intestinal tract, thus not increasing blood glucose levels and insulin content. Inulin can also greatly improve the absorption of minerals such as Ca2+, Mg2+, Zn2+, Cu2+, Fe2+ and the like, and can also regulate intestinal microbial flora, improve intestinal health and prevent constipation.
Researches show that locust bean gum and xanthan gum are not synergistic, and through a plurality of experimental researches, the inventors unexpectedly find that when konjac refined powder is compounded and used with xanthan gum, sodium pyrophosphate, locust bean gum and inulin according to a certain proportion, a synergistic effect can be achieved, so that the double-mushroom composite peptide plant beverage disclosed by the invention is more stable and uniform in property.
Compared with the prior art, the double-mushroom compound peptide composition and the preparation method and the application thereof have the following advantages:
(1) the invention can greatly reduce the use of the stabilizer in the beverage, and the addition amount of the stabilizer is reduced, but still can achieve better stabilizing effect and keep good flavor and taste of the beverage.
(2) The invention reduces the use of the stabilizer, thereby saving the manufacturing cost of the beverage and greatly improving the storage stability of the beverage.
(3) The double-mushroom compound peptide plant beverage provided by the invention is rich in nutrient components, and can play a remarkable health-care role, such as reducing blood fat and cholesterol, promoting digestion and absorption, preventing constipation, improving immunity and the like.
(4) The preparation method of the double-mushroom compound peptide plant beverage provided by the invention can effectively improve the yield of active substances, reduce the waste of raw materials and improve the uniformity and stability of the product quality.
Drawings
Figure 1 is a graph of the results of stability testing of beverages prepared according to the method of the present invention.
Detailed Description
The present invention is further described in the following description of the specific embodiments, which is not intended to limit the invention, but various modifications and improvements can be made by those skilled in the art according to the basic idea of the invention, within the scope of the invention, as long as they do not depart from the basic idea of the invention.
Example 1, a double-mushroom composite peptide composition, which comprises the following raw materials in parts by weight: 30 parts of probiotics, namely agaricus bisporus and flammulina velutipes composite powder, 1 part of fermented wheat protein peptide powder, 1 part of fermented soybean protein peptide powder and 1 part of white kidney bean extract.
Example 2, a double-mushroom composite peptide composition, which comprises the following raw materials in parts by weight: 70 parts of probiotic agaricus bisporus and flammulina velutipes composite powder, 20 parts of fermented wheat protein peptide powder, 10 parts of fermented soybean protein peptide powder and 4 parts of white kidney bean extract.
Example 3, a double-mushroom composite peptide composition, which comprises the following raw materials in parts by weight: 58 parts of probiotic agaricus bisporus and flammulina velutipes composite powder, 10 parts of fermented wheat protein peptide powder, 5 parts of fermented soybean protein peptide powder and 2 parts of white kidney bean extract.
Embodiment 4, a preparation method of probiotic agaricus bisporus and flammulina velutipes composite powder, which comprises the following specific steps:
(1) cleaning Agaricus bisporus and Flammulina velutipes (Fr.) Sing respectively, decocting in boiling water for 2 min, air drying, adding 8 times of water, crushing, centrifuging, collecting supernatant, filtering with filter cloth for 3 times, collecting filtrate, and freeze drying to obtain Agaricus bisporus dry powder and Flammulina velutipes dry powder;
(2) weighing 25 parts of agaricus bisporus dry powder and 20 parts of flammulina velutipes dry powder according to the parts by weight, mixing, sterilizing, homogenizing under the homogenizing pressure of 11MPa for 1.5 hours, and cooling the homogenized mixture to room temperature to obtain homogenized powder;
(3) adding Lactobacillus rhamnosus, Bifidobacterium animalis, and Bifidobacterium lactis, and mixing at 30 deg.C for 2 hr.
Example 5, a method for preparing a composite peptide composition from agaricus bisporus, comprising the steps of:
weighing 58 parts of probiotic agaricus bisporus and flammulina velutipes composite powder, 10 parts of fermented wheat protein peptide powder, 5 parts of fermented soybean protein peptide powder and 2 parts of white kidney bean extract according to the weight proportion, and mixing and stirring uniformly to obtain the agaricus bisporus composite peptide composition.
Example 6, a method for preparing a double-mushroom composite peptide plant beverage, comprising the following steps:
s1, preparing cranberry juice and blueberry juice: respectively taking fresh cranberries and blueberries, adding 4 times of water by weight, pulping, roughly filtering with 50-mesh filter cloth, filtering with 200-mesh filter cloth, taking filtered juice, and concentrating in vacuum to obtain cranberry concentrated juice and blueberry concentrated juice;
s2, weighing the stabilizer, grinding the stabilizer by using a colloid mill, mixing the stabilizer with the double-mushroom composite peptide composition, adding water to dissolve the stabilizer, stirring the mixture uniformly, heating and boiling the mixture for 7 minutes, cooling the mixture, and homogenizing the mixture by using a high-pressure homogenizer; and adding fructo-oligosaccharide, stachyose, green tea powder, green coffee powder, citric acid, the apple juice and the blueberry juice prepared in the step S1, homogenizing twice, filtering, sterilizing and filling to obtain the blueberry juice.
Wherein, the extraction conditions in the step S1 are that the aqueous solution is heated to 45 ℃ and the ultrasonic extraction time is 30 minutes; the combined filtrate obtained in step S1 is concentrated to a density of 1.0-1.2g/cm3(ii) a In step S4, the time for grinding the stabilizer by a colloid mill is 25 minutes, and the particle size of the ground stabilizer is 10-15 microns; the sterilization temperature in step S4 was 110 ℃, and the sterilization time was 10 minutes.
Example 7, a double-mushroom composite peptide plant beverage is composed of the following raw materials in percentage by weight:
3% of double-mushroom compound peptide composition, 10% of fructo-oligosaccharide, 1% of cranberry concentrated juice, 1% of blueberry concentrated juice, 1-5% of stachyose, 0.05% of green tea powder, 0.05% of green coffee powder, 0.1% of citric acid, 0.1% of stabilizer and the balance of water.
Wherein, the raw materials of the stabilizer comprise konjac powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin, and the weight ratio is 1:1.2:1.5:0.7: 5.
The preparation method is similar to example 6.
Example 8, a double-mushroom composite peptide plant beverage is composed of the following raw materials in percentage by weight:
8% of double-mushroom compound peptide composition, 18% of fructo-oligosaccharide, 4% of cranberry concentrated juice, 4% of blueberry concentrated juice, 5% of stachyose, 0.3% of green tea powder, 0.3% of green coffee powder, 0.3% of citric acid, 1% of stabilizer and the balance of water.
Wherein, the raw materials of the stabilizer comprise konjac powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin, and the weight ratio is 1:1.2:1.5:0.7: 5.
The preparation method is similar to example 6.
Example 9, a double-mushroom composite peptide plant beverage is composed of the following raw materials in percentage by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5% of stabilizing agent and the balance of water.
Wherein, the raw materials of the stabilizer comprise konjac powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin, and the weight ratio is 1:1.2:1.5:0.7: 5.
The preparation method is similar to example 6.
Example 10, a double-mushroom composite peptide plant beverage is composed of the following raw materials in percentage by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5% of stabilizing agent and the balance of water.
Wherein, the raw materials of the stabilizer comprise konjac powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin, and the weight ratio is 1:1:1:0.5: 3.
The preparation method is similar to example 6.
Example 11, a double-mushroom composite peptide plant beverage is composed of the following raw materials by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5% of stabilizing agent and the balance of water.
Wherein, the raw materials of the stabilizer comprise konjac powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin, and the weight ratio is 1:1.5:2:1: 6.
The preparation method is similar to example 6.
Comparative example 1, a double-mushroom compound peptide plant beverage is composed of the following raw materials in percentage by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid and the balance of water.
The preparation method is similar to example 6.
Comparative example 2, the double-mushroom compound peptide plant beverage is composed of the following raw materials in parts by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5 part of stabilizer and the balance of water.
Wherein the stabilizer is rhizoma Amorphophalli refined powder.
The preparation method is similar to example 6.
Comparative example 3, the double-mushroom compound peptide plant beverage is composed of the following raw materials in parts by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5 part of stabilizer and the balance of water.
Wherein the stabilizer is xanthan gum.
The preparation method is similar to example 6.
Comparative example 4, the double-mushroom compound peptide plant beverage is composed of the following raw materials in parts by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5 part of stabilizer and the balance of water.
Wherein the stabilizer is the mixture of locust bean gum and xanthan gum in a weight ratio of 1:1.
The preparation method is similar to example 6.
Comparative example 5, the double-mushroom compound peptide plant beverage is composed of the following raw materials in parts by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5 part of stabilizer and the balance of water.
Wherein the stabilizer is inulin.
The preparation method is similar to example 6.
Comparative example 6, a double-mushroom compound peptide plant beverage is composed of the following raw materials in parts by weight:
5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5 part of stabilizer and the balance of water.
Wherein, the stabilizer comprises the following raw material components in percentage by weight: konjac fine powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin in a weight ratio of 1:2:3:1.5: 8.
The preparation method is similar to example 1.
Test example I, stability test
Each of the samples prepared in examples 7 to 11 and comparative examples 1 to 6 was left at 37 ℃ for 4 weeks, and then the height of water evolution was observed and measured. The test results are shown in FIG. 1.
The above test results show that comparative example 1, which does not use a stabilizer, has the worst stability results; examples 7 to 11 using the stabilizers according to the invention are clearly superior to comparative examples 2 to 5 using a single stabilizer and also to comparative example 6 with a different weight ratio of the stabilizer components.
Second test example, evaluation test of taste and flavor
The two-mushroom composite peptide plant beverage provided by the embodiment 7-11 of the invention is evaluated in taste and flavor by respectively randomly selecting test crowds of 4 age stages, wherein each age stage is 60, and each group is 20, the evaluation criteria are shown in table 1, and the taste and flavor evaluation results are shown in table 2.
TABLE 1 functional evaluation criteria
TABLE 2 evaluation results of taste and flavor
As can be seen from the evaluation results in Table 2, the total satisfaction of the double-mushroom compound peptide plant beverage prepared by the invention reaches 94%, and the double-mushroom compound peptide plant beverage is rich in nutrition, good in taste and flavor and easy to accept by people.
In conclusion, the double-mushroom compound peptide plant beverage and the preparation method thereof provided by the invention have good stability, and still maintain good taste and flavor on the premise of using a small amount of stabilizer.
It will be appreciated by those skilled in the art that the above embodiments are merely illustrative of the principles and utilities of the present invention and are not intended to limit the invention. Any person skilled in the art can modify or change the above-mentioned embodiments without departing from the spirit and scope of the present invention. Accordingly, it is intended that all equivalent modifications or changes which can be made by those skilled in the art without departing from the spirit and technical spirit of the present invention be covered by the claims of the present invention.
Claims (10)
1. The double-mushroom composite peptide composition is characterized by comprising the following raw materials in parts by weight: 30-70 parts of probiotic agaricus bisporus and flammulina velutipes composite powder, 1-20 parts of fermented wheat protein peptide powder, 1-10 parts of fermented soybean protein peptide powder and 1-4 parts of white kidney bean extract.
2. The agaricus bisporus and flammulina velutipes composite peptide composition as claimed in claim 1, wherein the preparation method of the probiotic agaricus bisporus and flammulina velutipes composite powder comprises the following steps:
(1) cleaning Agaricus bisporus and Flammulina velutipes (Fr.) Sing respectively, decocting in boiling water for 2 min, air drying, adding 8 times of water, crushing, centrifuging, collecting supernatant, filtering with filter cloth for 3 times, collecting filtrate, and freeze drying to obtain Agaricus bisporus dry powder and Flammulina velutipes dry powder;
(2) weighing 20-30 parts of agaricus bisporus dry powder and 15-25 parts of flammulina velutipes dry powder in parts by weight, mixing, sterilizing, homogenizing at the homogenizing pressure of 10-13 MPa for 0.5-2.5 hours, and cooling the homogenized mixture to room temperature to obtain homogenized powder;
(3) and adding lactobacillus rhamnosus, bifidobacterium animalis and bifidobacterium lactis, and mixing at the temperature of 25-36 ℃ for 0.5-3 hours to obtain the lactobacillus acidophilus milk.
3. The preparation method of the double-mushroom composite peptide composition according to claim 1, comprising the following steps: weighing probiotic agaricus bisporus and flammulina velutipes composite powder, fermented wheat protein peptide powder, fermented soybean protein peptide powder and white kidney bean extract according to the weight ratio, mixing and uniformly stirring to obtain the agaricus bisporus composite peptide composition.
4. The use of the double-mushroom composite peptide composition according to any one of claims 1 to 3 in a plant beverage.
5. The use according to claim 4, wherein the plant beverage consists of the following raw materials in percentage by weight: 3-8% of double-mushroom compound peptide composition, 10-18% of fructo-oligosaccharide, 1-4% of cranberry concentrated juice, 1-4% of blueberry concentrated juice, 1-5% of stachyose, 0.05-0.3% of green tea powder, 0.05-0.3% of green coffee powder, 0.1-0.3% of citric acid, 0.1-1% of stabilizer and the balance of water.
6. The use according to claim 5, wherein the plant beverage consists of the following raw materials in percentage by weight: 5.8% of double-mushroom compound peptide composition, 15% of fructo-oligosaccharide, 2.79% of cranberry concentrated juice, 2.79% of blueberry concentrated juice, 2.5% of stachyose, 0.1% of green tea powder, 0.1% of green coffee powder, 0.2% of citric acid, 0.5% of stabilizing agent and the balance of water.
7. The use according to claim 6, wherein the stabilizer comprises the following raw material components: konjac fine powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin.
8. The use of claim 7, wherein the stabilizing agent comprises refined konjac flour, xanthan gum, sodium pyrophosphate, locust bean gum and inulin at a weight ratio of 1 (1-1.5) to (1-2) to (0.5-1) to (3-6).
9. The application of the stabilizing agent as claimed in claim 8, wherein the stabilizing agent comprises konjac refined powder, xanthan gum, sodium pyrophosphate, locust bean gum and inulin in a weight ratio of 1:1.2:1.5:0.7: 5.
10. Use according to any one of claims 4 to 9, wherein the preparation method of the vegetable beverage comprises the following steps:
s1, preparing cranberry juice and blueberry juice: respectively taking fresh cranberries and blueberries, adding 3-5 times of water by weight, pulping, roughly filtering with 50-mesh filter cloth, filtering with 200-mesh filter cloth, taking filtered juice, and vacuum concentrating to obtain cranberry concentrated juice and blueberry concentrated juice;
s2, weighing the stabilizer, grinding the stabilizer by using a colloid mill, mixing the stabilizer with the double-mushroom composite peptide composition, adding water to dissolve the stabilizer, stirring the mixture uniformly, heating and boiling the mixture for 5 to 10 minutes, cooling the mixture, and homogenizing the mixture by using a high-pressure homogenizer; and adding fructo-oligosaccharide, stachyose, green tea powder, green coffee powder, citric acid, the apple juice and the blueberry juice prepared in the step S1, homogenizing twice, filtering, sterilizing and filling to obtain the blueberry juice.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010560835.8A CN111743144A (en) | 2020-06-18 | 2020-06-18 | Double-mushroom composite peptide composition and preparation method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010560835.8A CN111743144A (en) | 2020-06-18 | 2020-06-18 | Double-mushroom composite peptide composition and preparation method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111743144A true CN111743144A (en) | 2020-10-09 |
Family
ID=72676429
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010560835.8A Pending CN111743144A (en) | 2020-06-18 | 2020-06-18 | Double-mushroom composite peptide composition and preparation method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111743144A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112741318A (en) * | 2021-01-13 | 2021-05-04 | 漳州绿优品食品科技有限公司 | Cell activation beverage and preparation method thereof |
CN115211480A (en) * | 2022-06-22 | 2022-10-21 | 嘉应学院 | Compound tea solid beverage and production method thereof |
CN117925444A (en) * | 2023-12-07 | 2024-04-26 | 无限极(中国)有限公司 | Chinese herbal medicine composition for promoting growth of probiotics and application thereof |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1793380A (en) * | 2004-12-26 | 2006-06-28 | 陆晓民 | Process and application for producing fermant protein peptide |
CN105851756A (en) * | 2016-04-25 | 2016-08-17 | 华南理工大学 | Corn peptide beverage containing fermented carrot juice and preparation method thereof |
CN108142770A (en) * | 2017-12-18 | 2018-06-12 | 沈阳润东生物科技有限公司 | A kind of polynary probiotics solid beverage of breast peptide |
CN109497531A (en) * | 2018-12-25 | 2019-03-22 | 厦门元之道生物科技有限公司 | A kind of fermentation collagen peptide and preparation method thereof |
CN109566922A (en) * | 2018-12-02 | 2019-04-05 | 深圳美丽魔方健康科技有限公司 | Compound beverage and preparation method thereof |
CN110200186A (en) * | 2019-07-15 | 2019-09-06 | 无限极(中国)有限公司 | A kind of probiotics solid beverage and preparation method thereof |
CN111109492A (en) * | 2020-01-14 | 2020-05-08 | 上海昊岳食品科技有限公司 | Functional collagen peptide probiotic solid beverage and preparation method thereof |
CN111165815A (en) * | 2020-01-13 | 2020-05-19 | 吴心芬 | Weight-losing nutritional meal replacement composition |
-
2020
- 2020-06-18 CN CN202010560835.8A patent/CN111743144A/en active Pending
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1793380A (en) * | 2004-12-26 | 2006-06-28 | 陆晓民 | Process and application for producing fermant protein peptide |
CN105851756A (en) * | 2016-04-25 | 2016-08-17 | 华南理工大学 | Corn peptide beverage containing fermented carrot juice and preparation method thereof |
CN108142770A (en) * | 2017-12-18 | 2018-06-12 | 沈阳润东生物科技有限公司 | A kind of polynary probiotics solid beverage of breast peptide |
CN109566922A (en) * | 2018-12-02 | 2019-04-05 | 深圳美丽魔方健康科技有限公司 | Compound beverage and preparation method thereof |
CN109497531A (en) * | 2018-12-25 | 2019-03-22 | 厦门元之道生物科技有限公司 | A kind of fermentation collagen peptide and preparation method thereof |
CN110200186A (en) * | 2019-07-15 | 2019-09-06 | 无限极(中国)有限公司 | A kind of probiotics solid beverage and preparation method thereof |
CN111165815A (en) * | 2020-01-13 | 2020-05-19 | 吴心芬 | Weight-losing nutritional meal replacement composition |
CN111109492A (en) * | 2020-01-14 | 2020-05-08 | 上海昊岳食品科技有限公司 | Functional collagen peptide probiotic solid beverage and preparation method thereof |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112741318A (en) * | 2021-01-13 | 2021-05-04 | 漳州绿优品食品科技有限公司 | Cell activation beverage and preparation method thereof |
CN115211480A (en) * | 2022-06-22 | 2022-10-21 | 嘉应学院 | Compound tea solid beverage and production method thereof |
CN117925444A (en) * | 2023-12-07 | 2024-04-26 | 无限极(中国)有限公司 | Chinese herbal medicine composition for promoting growth of probiotics and application thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105918821A (en) | Compound enzyme liquid having effects of lowering high blood lipids, high blood pressure and high blood sugar, and improving immunity, and preparation method thereof | |
CN108812909B (en) | Complementary food nutritional supplement for improving monophagia or anorexia and preparation method thereof | |
CN106135977B (en) | Production method of calcium fruit powder with functions of supplementing calcium and improving eyesight | |
CN107581436B (en) | Preparation method of concentrated medlar pulp by probiotics fermentation | |
CN107691955A (en) | Probiotics solid beverage and preparation method thereof | |
CN110037257A (en) | A kind of formula and preparation method of immunological regulation and enhancing physical strength | |
CN111743144A (en) | Double-mushroom composite peptide composition and preparation method and application thereof | |
CN106578801A (en) | Comprehensive enzyme powder with hypoglycemic effect and preparation method thereof | |
CN111743000A (en) | Composite peptide composition and preparation method and application thereof | |
CN104664511A (en) | Cereal-vegetable-fruit beverage and preparation method thereof | |
CN105309979A (en) | Edible fungi functional beverage and preparation method thereof | |
CN103609706A (en) | Mixed drink good for eyesight | |
CN110367410B (en) | Compound lactobacillus fruit juice beverage and preparation method thereof | |
CN113186066A (en) | SOD wine capable of preserving health and tonifying kidney and preparation method thereof | |
CN113317374A (en) | Preparation method of fermented beverage | |
CN104012651B (en) | A kind of Fructus Pruni pseudocerasi collagen polypeptide Fe clabber | |
CN108064941B (en) | Lily lotus seed yoghourt and preparation method thereof | |
CN105661212A (en) | Corn and tremella clear juice beverage and preparation method thereof | |
CN107361355A (en) | A kind of preparation method of jujube ferment powder | |
CN110801003A (en) | Calcium fruit enzyme powder and preparation method thereof | |
CN115644331A (en) | Preparation method of sea cucumber and oyster compound peptide beverage capable of effectively improving anti-fatigue function | |
KR102476078B1 (en) | Manufacturing method of yogurt powder | |
KR20200023053A (en) | Powder type multiple food supplement comprising beta glucan powder, chitosan powder, acerola extract powder, ganoderma lucidum fruit body powder, grifola frondosa powder, lentinus edodes mycelium powder, lycium chinense powder, aloe powder, angelica gigas extract powder and ginseng extract powder | |
CN107156570A (en) | It is a kind of be of high nutritive value, the preparation method for the five cereals sour milk beverage that heat is low, local flavor is excellent, stability is good | |
CN111357893A (en) | Truffle oral liquid and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20201009 |
|
RJ01 | Rejection of invention patent application after publication |